- FDA chastises Vista Pharma for not paying generic drug user fees (biopharmadive.com)
FDA sent a warning letter to Vista Pharmaceuticals, which is based in India, for not paying Generic Drug User Fee Act fees on time. This is the fourth time this month.. Failure to pay... fees is an international problem. This month alone, companies in India, the U.S. and China were fined for failure to pay in a timely manner.
- Stage 3 meaningful use ignores market realities, says Brookings (healthcareitnews.com)
third stage of meaningful use,..the requirements for greater participation of doctors and hospitals, is now coming under even more fire than the program has seen in the past…requires providers to send electronic summaries for 50 % of patients they refer…,receive summaries for 40% of patients that are referred...reconcile past patient data with current reports for 80% of such patients.
- Hunt faces backlash over 7-day NHS comments (pharmatimes.com)
Jeremy Hunt (Health Secretary) is a facing a growing backlash over his comments during a speech on the National Health Service (United Kingdom)...he essentially gave doctors an ultimatum to get on board with seven-day working....threatened to impose a new contract for doctors if negotiations to.. end the "monday to friday" culture...are unsuccessful.
- Will Bovine Heparin Be Reintroduced into the U.S. Market? (qualitymatters.usp.org)
U.S. regulators are considering the reintroduction of bovine heparin.. Today, all heparin products… are derived from pigs… Seventy-five percent of the crude porcine heparin…comes from outside of the U.S., with a majority of that percentage originating from China… reintroduction of bovine heparin into the U.S. market would expand sources…
- AMA docs fed up with EHR woes (healthcareitnews.com)
When it comes to electric health records (EHR), many docs are more frustrated than ever. "They have so much potential to improve healthcare, improve quality, improve our efficiency, improve patient engagement, and yet that's not the current state of reality,"… "Our experience as physicians is often falling far short of the promise…"
- Doctors Earn More Than $54 Million in Bonus Payments From UnitedHealthcare for Improving Health Outcomes and Closing Gaps in Care (marketwatch.com)
More than 4,000 care providers recognized with Positive Actions Toward Health Excellence in Patient Service Awards for hitting key quality measures in treatment of Medicare Advantage membersProgram is helping encourage transition to value-based payments from fee-for-service approach..
- Researching Marijuana for Therapeutic Purposes: The Potential Promise of Cannabidiol (CBD) (drugabuse.gov)
..before the Senate on cannabidiol,…hearing was to explore ways we can reduce obstacles to research…, given that all chemicals in the marijuana plant are currently in the most restricted category of the Drug Enforcement Administration’s schedule of controlled substances—schedule I…Medical research can and is being done with schedule I substances; however, there are strict regulations and administrative hurdles...
- New CMS rules may spur EHR uptake (healthcareitnews.com)
Long-term care's digital moment?...Proposed new rules for long-term care released…could spur an uptake of electronic health records by nursing homes across the country…
- Jeremy Hunt: ‘10% more GPs for seven-day week work load’ (bbc.com)
government (United Kingdom) is promising a "new deal" for general practitioners in England if they sign up to seven-day opening…Health Secretary Jeremy Hunt said he will increase the GP workforce by 10% to deal with the added workload. (video)
- AB Science hit with FDA warning letter over clinical trials (outsourcing-pharma.com)FDA Warning Letter - AB Science (fda.gov)
France’s AB Science has received a warning letter from the US FDA for its failure to adhere to agency regulations and to protect trial subjects’ safety in a pancreatic cancer study...


